 Analysts at Needham Company LLC initiated coverage on shares of Aerie Pharmaceuticals NASDAQ:AERI in a research report issued on Friday, TipRanks reports. The brokerage set a buy rating and a 38.00 price target on the stock. Needham Company LLCs price target indicates a potential upside of 143.59 from the companys current price. A ... 